Company / Current Assets
PUMA BIOTECHNOLOGY, INC. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$162.7M
FY2025
5-year range
$134.3M / $162.7M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 9 years, ranging from $106M in FY2017 to $203M in FY2018.
Based on SEC 10-K filings.
$163M in FY2025 with a 5-year CAGR of +2.2%.
Improved from $156M to $163M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.2%, indicating consistent growth.
- In FY2025, current assets increased 10.2% year-over-year.
- Peak current assets was recorded in FY2018.
- Lowest current assets in the period was in FY2017.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $162.7M | +10.2% |
| FY2024 | $147.7M | -5.5% |
| FY2023 | $156.2M | +16.3% |
| FY2022 | $134.3M | -4.1% |
| FY2021 | $140.0M | -4.2% |
| FY2020 | $146.1M | -12.1% |
| FY2019 | $166.3M | -18.1% |
| FY2018 | $203.0M | +90.8% |
| FY2017 | $106.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026